SCHEMBL21276712

SCHEMBL21276712

O=CNc1ccc(C#Cc2cnc3cc(OCCN4CCOCC4)cnn23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 1/20 0.41
▸ KDR P35968 1/20 0.39
▸ KMT2A Q03164 1/20 0.38
▸ CFTR P13569 1/20 0.38
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA7 P43166 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ NR3C1 P04150 1/20 0.37
▸ CACNA1B Q00975 1/20 0.37
▸ APBA1 Q02410 1/20 0.37
▸ HRH2 P25021 1/20 0.37
▸ HRH1 P35367 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21276713 0.96 HRH3 (0.42) KDRCYP1A2HRH2HRH1HRH3
SCHEMBL21276813 0.84 MAPK1 (0.44) ACACBKDRCYP1A2HRH2HRH1
SCHEMBL21276707 0.82 ACACB (0.39) ACACBKDRKMT2ACYP1A2CYP3A4
SCHEMBL21276770 0.80 MCHR1 (0.50) ACACBKMT2ACA12CA1CA2
SCHEMBL17447611 0.79 RET (0.59) KDRMAPK14RET
SCHEMBL21276708 0.78 HRH3 (0.59) ACACBCYP1A2HRH2HRH1HRH3
SCHEMBL21276670 0.78 MCHR1 (0.50) ACACBKMT2ACA12CA1CA2
SCHEMBL21276827 0.77 MCHR1 (0.45) ACACBKMT2ACA12CA1CA2
SCHEMBL14368318 0.77 CA12 (0.58) KMT2ACA12CA1CA2CA7
SCHEMBL21276690 0.75 PRKAB1 (0.47) ACACBKDRNR3C1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169671-B1 1-(5-(TERT.-BUTYL)ISOXAZOL-3-YL)-3-(4-((PHENYL)ETHYNYL)PHENYL)UREA DERIVATIVES AND RELATED COMPOUNDS AS FLT3 INHIBITORS FOR TREATING CANCER SUNSHINE LAKE PHARMA CO LTD (CN) 2019-08-21 — — EP disclosed
Send feedback